Concepedia

Publication | Closed Access

Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia

104

Citations

10

References

2011

Year

References

YearCitations

Page 1